I know enough to ask questions about whether the company can assure us all that phase 2's are just around the corner when safety is not established at the possible dosing regimens they may propose. The FDA has not said yes to their phase 2 trials yet.
Until I started banging on this drum I read nothing about the topic here on the board.
as an investor i will be sad if we get a pr that says phase 2 trials will be delayed 18 months while Dana Farber conducts add on dose optimization studies.
But yes you are right we can all just wait and see..and not bother to wonder about anything at all. Just sort of sit here, quietly, and not pose even simple questions.